T. Rowe Price Associates’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $490K | Buy |
|
|||||
|
2023
Q2 | $243K | Buy |
|
|||||
|
2023
Q1 | $290K | Buy |
|
|||||
|
2022
Q4 | $265K | Buy |
|
|||||
|
2022
Q3 | $293K | Buy |
|
|||||
|
2022
Q2 | $270K | Sell |
|
|||||
|
2022
Q1 | $340K | Sell |
|
|||||
|
2021
Q4 | $447K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $20.1M | Sell |
|
|||||
|
2020
Q1 | $34.6M | Sell |
|
|||||
|
2019
Q4 | $80.4M | Buy |
|
|||||
|
2019
Q3 | $12.8M | Sell |
|
|||||
|
2019
Q2 | $15.5M | Sell |
|
|||||
|
2019
Q1 | $22M | Buy |
|
|||||
|
2018
Q4 | $741K | Sell |
|
|||||
|
2018
Q3 | $992K | Buy |
|
|||||
|
2018
Q2 | $445K | Buy |
|
|||||
|
2018
Q1 | $320K | Sell |
|
|||||
|
2017
Q4 | $511K | Buy |
|
|||||
|
2017
Q3 | $287K | Sell |
|
|||||
|
2017
Q2 | $2.34M | Sell |
|
|||||
|
2017
Q1 | $2.3M | Sell |
|
|||||
|
2016
Q4 | $12M | Buy |
|
|||||
|
2016
Q3 | $18.1M | Buy |
|
|||||
|
2016
Q2 | $3.25M | Sell |
|
|||||
|
2016
Q1 | $3.03M | Sell |
|
|||||
|
2015
Q4 | $50.4M | Sell |
|
|||||
|
2015
Q3 | $56.3M | Buy |
|
|||||
|
2015
Q2 | $79.2M | Sell |
|
|||||
|
2015
Q1 | $114M | Buy |
|
|||||
|
2014
Q4 | $40M | Sell |
|
|||||
|
2014
Q3 | $62.2M | Sell |
|
|||||
|
2014
Q2 | $147M | Buy |
|
|||||
|
2014
Q1 | $187M | Buy |
|